Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
about
Addressing the Global Burden of Trauma in Major Surgery2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theSex differences in cardiovascular disease - Impact on care and outcomes.Management standards for stable coronary artery disease in India.Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.Beta-blocking agents in cardiovascular disease; are they here to stay?Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.Effect of Beta Blockers and Renin-Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionEffectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.A meta-analysis of the effects of β-adrenergic blockers in chronic heart failureRelationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionHistorical perspective and contemporary management of acute coronary syndromes: from MONA to THROMBINS2.Acute coronary syndromes in women and men.Mortality reduction with use of oral beta-blockers in patients with acute coronary syndromeDrug Therapy for Stable Angina Pectoris.Beta Blocker Administration During Emergency Department Evaluation for Acute Coronary Syndrome Is Associated With Lower Posttraumatic Stress Symptoms 1-Month Later.Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.Influence of the previous use of β-blockers on the early clinical course of acute coronary syndromes.Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.Expert consensus document: A 'diamond' approach to personalized treatment of angina.β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2).Repetition rescues regenerative reserve.Beta-blockers for non-acute treatment after myocardial infarctionBeta-blockers for suspected or diagnosed acute myocardial infarction
P2860
Q26782817-DB0C7731-BA67-4258-ACDE-7B3F7D4EC018Q28087002-156078D3-57F2-4618-BC4A-0DB22F91B27BQ30234726-66CF197B-8A81-48A1-8B8F-7078726E00E3Q30239853-21508F0B-3437-4C9B-8DC5-73FF5A9913BAQ33552609-E4343905-1AF1-44BD-9683-B04B7EDCB254Q35337661-FB326DDE-53B1-4841-A2E1-9E7CF96A12CFQ36094414-68A61562-262E-4477-BBF4-B5DF58E54C30Q37207039-F7F8FC9C-899A-4908-BA42-5D1DC7A88575Q37250491-B0B09750-2BD7-4FC2-B29D-F2858C540DD4Q37268109-983C08B3-4AA0-4BFD-9464-8E15328B5DFCQ37289514-13A508CC-D086-4D72-88E7-C37844D4BF12Q37556186-1B9D3C1B-D206-475D-B285-C7B69C485A9FQ38604841-95766AEC-7F6B-4E75-8735-970954191DE7Q38852088-2CED8DAF-BD5F-412E-9799-0977FE30C723Q39095735-1D98F691-2834-473F-9DE2-E73CF6CA9419Q39102158-577BB049-603F-4FD3-905F-2984BCE81315Q40179283-9BD93D6B-EE92-4279-B48A-B4F4E7A5679EQ40636989-06A492ED-BCB1-4CBE-94F8-6D366B497D9EQ40922839-0E89CF04-1527-42CA-9210-6BB3108CD1C3Q47098635-17C90ED1-3966-4FBE-8952-4EAB07F0DAFDQ48022963-02DE4B6B-C416-49BE-9501-DB8931A99405Q49234909-BFEF0D26-4B00-442F-9B93-5ECCE2A1D800Q50546099-9558F39A-AED2-4E26-BC47-96407783460CQ57389407-C8EEC9F2-C17D-485E-B5F1-91A196F74CC3Q57389442-6643D85C-D6D7-4FBE-834C-FDAA59B98925
P2860
Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@ast
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@en
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@en-gb
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@nl
type
label
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@ast
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@en
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@en-gb
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@nl
altLabel
Clinical outcomes with β-block ...... -analysis of randomized trials
@en
prefLabel
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@ast
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@en
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@en-gb
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@nl
P2093
P50
P3181
P1476
Clinical Outcomes with β-Block ...... -analysis of Randomized Trials
@en
P2093
Bora Toklu
Franz H. Messerli
Harikrishna Makani
Jorn Wetterslev
Karen P. Alexander
P304
P3181
P356
10.1016/J.AMJMED.2014.05.032
P407
P577
2014-10-01T00:00:00Z